Canada · Health Canada Drug Product Database
INFANRIX-IPV/HIB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 74234
- DIN
- 02257122
- Form
- Suspension
- Company as listed by source
- GLAXOSMITHKLINE INC
- Source status
- Marketed (2026-04-06)
- Source last updated
- 2026-04-17
Source-listed ingredients
- PERTUSSIS TOXOID — 25 MCG — per 0.5 ML
- FILAMENTOUS HAEMAGGLUTININ — 25 MCG — per 0.5 ML
- PERTACTIN — 8 MCG — per 0.5 ML
- DIPHTHERIA TOXOID — 30 UNIT — per 0.5 ML
- TETANUS TOXOID — 40 UNIT — per 0.5 ML
- INACTIVATED POLIOVIRUS TYPE I — 40 UNIT — per 0.5 ML
- INACTIVATED POLIOVIRUS TYPE II — 8 UNIT — per 0.5 ML
- INACTIVATED POLIOVIRUS TYPE III — 32 UNIT — per 0.5 ML
- HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE (PRP-T) — 10 MCG — per 0.5 ML
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →